Alexandra Drakaki

APLA Health — United States

Medicine · Health Sciences

14h-index1.5kcitations74works2.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(23), Bladder and Urothelial Cancer Treatments(21), Renal cell carcinoma treatment(11), Urinary and Genital Oncology Studies(11), MicroRNA in disease regulation(6)

Publications73 total

Abstract B039: T-cell–dominated interferon signaling drives immune checkpoint inhibitor–associated pneumonitis and reveals actionable cytokine targets
Cancer Immunology Research·2026
A non-canonical EZH2/TRIM28 epigenetic axis drives heparan sulfate remodeling and melanoma metastasis
2026Open Access
Abstract 4373293: Immune Checkpoint Inhibitor Thyroid Dysfunction is Associated with Increased Incidence of Coronary Artery Disease and Arrhythmia
Circulation·2025
Abstract A023: Erythropoietin (EPO) is a Pharmacodynamic Biomarker for Systemic HIF-2α Inhibition that Correlates with the Clinical Activity of Casdatifan
Molecular Cancer Therapeutics·2025
PD37-09 The First Report Of Disease-Free Survival Analyses From The Niagara Trial Of Perioperative Durvalumab Plus Neoadjuvant Chemotherapy In Muscle-Invasive Bladder Cancer: Erratum
The Journal of Urology·2025
Early Growth Response-2 is involved in regulation of fibrogenesis-related genes in macrophages
2025
3073P Enfortumab vedotin (EV) + pembrolizumab (P) in previously untreated locally advanced or metastatic urothelial cancer (la/mUC): An exploratory analysis in older patients (pts) and those with comorbidities from EV-302
Annals of Oncology·2025
Uncovering an unconventional JAK1/2-STAT3 branch in macrophage IFNγ signaling
2025Open Access
ALLO-316 in advanced clear cell renal cell carcinoma (ccRCC): Updated results from the phase 1 TRAVERSE study.
Journal of Clinical Oncology·2025· 4 cited
Preliminary results from a first-in-human phase 1 dose escalation trial of ADRX-0706, a next generation Nectin-4 ADC, in subjects with advanced solid tumors.
Journal of Clinical Oncology·2025· 1 cited
Response and Survival With Immune Checkpoint Inhibitor in Patients With Advanced Urothelial Carcinoma and Histology Subtypes
Clinical Genitourinary Cancer·2025· 2 cited
PD37-09 THE FIRST REPORT OF DISEASE-FREE SURVIVAL ANALYSES FROM THE NIAGARA TRIAL OF PERIOPERATIVE DURVALUMAB PLUS NEOADJUVANT CHEMOTHERAPY IN MUSCLE-INVASIVE BLADDER CANCER
The Journal of Urology·2025
Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study
Journal for ImmunoTherapy of Cancer·2025· 5 citedOpen Access
Uncovering an Unconventional JAK1/2-STAT3 Branch in Macrophage IFNγ Signaling
SSRN Electronic Journal·2025Open Access
Frontiers in Systemic Therapy for Unresectable or Metastatic Adrenocortical Carcinoma: Harnessing Novel Therapeutic Approaches
Clinical Medicine Insights Oncology·2025· 1 citedOpen Access
Molecular Diversity of Embryonic-Type Neuroectodermal Tumors Arising From Testicular Germ Cell Tumors
Modern Pathology·2024· 3 cited
Clinical Outcomes With Immune Checkpoint Inhibitors in Patients With FGFR2/3, MTAP or ERBB2 Genomic Alterations in Advanced Urothelial Carcinoma
Clinical Genitourinary Cancer·2024· 1 cited
Abstract 4145712: Cancer Type and Baseline Cardiometabolic Risk Factors Predict Major Adverse Cardiac Events in Patients Receiving Immune Checkpoint Inhibitor Therapy
Circulation·2024· 1 cited
481 Single cell sequencing of human ICI-thyroiditis and ICI-colitis reveals a shared role for T follicular and T peripheral helper cells in the development of IRAEs across tissues
Regular and Young Investigator Award Abstracts·2024Open Access
PD-1 blockade plus cisplatin-based chemotherapy in patients with small cell/neuroendocrine bladder and prostate cancers
Cell Reports Medicine·2024· 8 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Dimitrios Iliopoulos(8), Petros Grivas(8), Allan J. Pantuck(7), Tanya Jindal(7), Vadim S. Koshkin(7), Daniel Castellano(7), Ali Raza Khaki(7), Ignacio Durán(6), Dimitra Rafailia Bakaloudi(6), Rafee Talukder(6), Dimitrios Makrakis(6), Jason R. Brown(6), Yousef Zakharia(6), Rafael Morales‐Barrera(6), Rana R. McKay(6), Christos Polytarchou(5), Leonidas Nikolaos Diamantopoulos(5), Nishita Tripathi(5), Neeraj Agarwal(5), Aristotelis Bamias(5)